EGVRS International Meeting, January 9 11, 2013

Size: px

Start display at page:

Download "EGVRS International Meeting, January 9 11, 2013"

Dulcie Walsh
5 years ago
Views:

1 EGVRS International Meeting, January 9 11, 2013 Wednesday January 9 th, 2013 Instruction Courses Thursday January 10 th, :00 1:00 Live Surgery Moderators: From Cairo& Belgium From operation Theatres: o Sherif Sheta o Mostafa Nabih o Hany Hamza From Conference Hall o Khaled El Rakhawy o Mahmoud Soliman o Borja Corcostegui Surgeons o Kazuaki Kadonosono, Japan o Mostafa Nabih, Egypt o Maria Berrocal, Puertorico o Ramzi Avci, Turkey o Sherif Sheta, Egypt o Jeroni Nadal, Spain o Peter Stalmans, operating from University hospital Leuven, Belgium o Hassan Mortada, Egypt o Hany Hamza, Egypt

2 1:00 1:45 Lunch o Mohamad Moghazy, Egypt 1:45 2:00 Keynote Lecture: Evolution of the management of myopic macular hole retinal detachment in Egypt. Professor Dr. Omar Rashed Session 1 2:00 3:30 Rhegmatogenous Retinal Detachment &PVR. 8 minutes presentations Chair: Scleral buckling: Indications update: B. Cocostegui Pars plana vitrectomy and long acting gas tamponade for severe primary retinal detachment: R. Avci Treatment of retinal detachment with PVR: J. Nadal Microincisional Surgery in PVR: M. Berrocal The outcome of 23G pars plana vitrectomy without scleral buckle for management of retinal detachment: M. El Deeb Bimanual approach in management of complicated rhegmatogenous retinal detachment: F. Fayaad

3 ILM removal in primary vitrectomy for uncomplicated retinal detachment : K. El Rakhawy Rhegmatogenous retinal detachment: having everything in hand: W. Ewais Decorin and PVR: M. Soliman Iris reconstruction in aniridia and silicone oil tamponade surgery. T. Wolfensberger Discussion 3:30 3:45 Coffee Break Session 2 3:45 5:00Pediatric Vitreoretinal disorders 8 minutes presentations. Chair: Correlation between risk factors during the neonatal period and the appearance of retinopathy of prematurity in preterm infants. A. Abdel Hadi, I. Hamdy ROP: Physiopathology, screening and treatmernt. S. Tiexiera Treatment outcomes of combined laser with intravitreal bevacizumab versus laser treatment alone in cases of stage 3+ ROP. M. Tameesh

4 Discussion Session 3 Anti-VEGF therapy in ROP. S. Tiexiera Current Coats disease treatement. B. Corcostegui Management of optic disc pit. M. Berrocal Optic disc pit Maculopathy treated with vitrectomy, peripapillary endolaser photocoagulation and gas tamponade. R. Avci Pediatric rhegmatogenous retinal detachment, clinical features and surgical outcomes. A. Khatab 5:00 7:00VideoPanel discussion: Challenging situations Moderator: Hassan Mortada 8:00 Gala Dinner Friday January 10, 2013 Session 4 8:00 8:45 Video session 8:45 9:30Tumors & Related Conditions 8 minutes presentations Chair:

5 Wide angle fundus imaging and fluorescein angiography in evaluation and management of intraocular tumors. I. saad New approach in the treatment of juxtapapillary hemangioma. J. Nadal Tumorectomy after proton beam irradiation for choroidal melanoma. T. Wolfensberger Long term results of vitreoretinal surgery for severe Von Hippel Lindau retinal angiomatosis. R. Avci Session 5 9:30 11:00Diabetic Vitrectomy Chair: 8 minutes presentations Grading system & surgical prognosis in proliferative diabetic retinopathy. B. Corcostegui Preoperative Bevacizumab. M. Berrocal Vitrectomy with visco-dissection for proliferative diabetic retinopathy. K. Kadonosono 23g probe segmentation/delamination in complicated diabetic vitrectomy. H. Mortada

6 Discussion Management of severe proliferative diabetic retinopathy with today s available techniques. F.Fayaad Treatment of recurrent hemorrhage post pars plana vitrectomy in patients with proliferative diabetic retinopathy. M. Portavella, E. Beltran, B. Kudsieh, J. Nadal ILM in diabetic vitrectomy. To peel or not to peel. A. El Sawy Evaluation of safety and efficacy of intravitreal bevacizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage. A. Lotfy Session 6 11:00 11:45 Symposium I: Macular Edema Update Vascular endothelial growth factor gene polymorphism in diabetic macular edema and its correlation with anti-vegf treatment outcome. S. El Shazely Intravitreal diclofenac versus intravitreal triamcinolone for diffuse diabetic macular edema: Preliminary results. M.S. El Agha, S. Hegazy, M. El Malt, M. El Sada Intravitreal bevacizumab alone versus combination with intravitreal triamcinolone

7 Discussion acetonide in the treatment of macular edema. N.Khater, N. Hussein Role of vitrectomy in diffuse diabetic macular edema. M. Berrocal Surgical treatment of diabetic macular edema. Samir El Baha 11:45 01:30 Gomaa Prayer and Lunch 1:30 1:50 Novartis Lecture: Simon Kelly Session 7 1:50 : 3:00 Retina Debates Moderators: Sherif Imbabi & Mohamed Moghazi Session 8: 3:00 4:20Surgical Techniques 8 minutes presentations Chair: Retinal endovascular treatment for central retinal vein occlusion. K. Kadonosons Sheathotomy combined with retinal endovascular treatment for branch retinal vein occlusion. K. Kadonosono Management of vascular occlusion. M. Berrocal

8 Discussion Macular Buckling. A. Siam Different techniques of transconjunctival sutureless vitrectomy versus conventional vitrectomy in various vitreoretinal disorders. H. Ghoraba, S. El Gouhary, A. Ellakaw Vitreoretinal surgery in patients with keratoprosthesis, Boston and Osteo-Odonto. J. Nadal Outcome of penetrating keratoplasty and sulcus fixated intraocular lens combined with vitreoretinal surgery using temporary keratoprosthesis. W. Abdel Ghaffar, A. Abdel Salam Practical tips & tricks in combined phacovitrectomy. P. Stalmans Vitrectomy in Uveitis. M. Berrocal Session 8 4:20 5:00Vitreo-retinal interface disorders Chair Macular microstructure in eyes with spontaneous resolution of macular hole by OCT. K. Kadonosono Microperimetric evaluation of Brilliant Blue G assisted internal limiting membrane peeling. Y. Sarag, T. Wasfi, ES. El Dessoukey, M.Mousa, A. Kampik.

9 Use of Ocriplasmin to treat Vitreomacular traction and macular holes. P. Stalmans Diabetic Macular holes: Is ILM peeling mandatory?. A. Shaarawy, A. Bessa, M Lolah. Discussion Pharmacological adjuvant therapy in epiretinal membrane surgery. T. Wolfensberger Session 9 5:00 5:45 Rapid-Fire Presentations 5 minutes presentations Surgical technique for flattening of macular fold in a child. H. Hamza Evaluation of vitreoretinal adhesion in choroidal neovacularization using OCT. A. Ramadan, M. Alaa Visual aids simplifying vitrectomy. Maged Mikhael Surgical management of optic disc pit Maculopathy. M. Diez, M. Portavella, B. Kudsieh, J. Nadal Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab and subsequent trabeculectomy with mitomycin. A. Al Kawas, E. Shahein, A. Hussein

10 Combined phacoemulsification & trans-posterior CCC silicone oil removal through a small corneal incision. A.A. Ehnaidy Dropped lens matter, avoiding and dealing with the disaster. T. Maamoun Discussion Quadriple approach for the treatment for the treatment of silicone oil induced glaucoma. A. Saeed Session 10 5:45 7:00 Medical Retina Chair A fast technique for pan retinal photocoagulation. Y. Serag Stem cell therapy and the retina. W. Abou Elkheir Effect of human CB-derived stem cells on induced diabetic retinopathy in albino rats: histological and immunohistochemical study. H. Gaber, Z. El Maadawi Prognostic parameters of SD-OCT in AMD. Z. El Sanabary Corrollating SD-OCT, FAF and Fain a case of Doyne Honeycomb retinal dystrophy. Tarek Hemeida New hope for chronic CSR. A. Azab

11 Comparison of two different Bevacizumab protocol in the treatment of myopic CNVM. M. El Baradey

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona FINAL PROGRAM III TRENDS IN SURGICAL & MEDICAL RETINA Live Surgery and Round Tables Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona Join the IMO team and eminent guest surgeons in